Symptoms of chronic bronchitis and the risk of coronary disease

Lancet

Volumn 348, Issue 9027, 1996, Pages 567-572

  Jousilahti, Pekka ^a   Vartiainen, Erkki ^a   Tuomilehto, Jaakko ^a   Puska, Pekka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC BRONCHITIS; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SMOKING; SYMPTOM; SYSTOLIC BLOOD PRESSURE;

EID: 0030608226     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)02374-4     Document Type: Article

References (30)

1. 1 Cardiovascular diseases risk factors: new areas for research. Geneva: WHO Tech Rep Ser 841, 1994.
2. 2 Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993 (suppl K): 14: 12-16.
3. 3 McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT. Cytomegalovirus disease link to coronary artery disease. Am J Cardiol 1989; 64: 359-62.
4. 4 Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-39.
5. 5 Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53: 481-82.
6. 6 Mattila KJ. Viral and bacterial infections in acute myocardial infarction. J Intern Med 1989; 225: 293-96.
7. 7 Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary artery disease in the Helsinki Heart study. Ann Intern Med 1992; 116: 273-78.
8. 8 Thom DH, Wang S-P, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991; 11: 547-51.
9. 9 Odeh M, Oliven A. Chlamydial infections and the heart: a review. Eur J Clin Microbiol Inf Dis 1992; 11: 885-93.
10. 10 Grayston JT, Cambell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618-25.
11. 11 Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of novel Chlamydia, TWAR, with chronic coronary artery disease and acute myocardial infarction. Lancet 1988; ii: 983-86.
12. 12 Godzik KL, O'Brien ER, Wang S-K, Kuo C-C. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995; 33: 2411-14.
13. 13 Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary artery disease. J Infect 1995; 30: 121-28.
14. 14 Puska P, Tuomilehto J, Salonen J, et al. Community control of cardiovascular disease - The North Karelia Project: evaluation of a comprehensive community programme for control of cardiovascular diseases in 1972-1977 in North Karelia. Copenhagen: World Health Organization, Regional Office for Europe, 1981.
15. 15 Rose GA, Blackburn H. Cardiovascular survey methods. Geneva: World Health Organization, 1968.
16. 16 Szczeklik A, Dropinski J, Gora PF. Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction. Coronary Artery Disease 1993; 4: 1029-32.
17. 17 Karvonen M, Tuomilehto J, Pitkäniemi J, Saikku P. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987. Epidemiol Infect 1993; 110: 349-60.
18. 18 Matthay RA. Chronic airways disease. In: Wyngaarden JB, Smith LH, ed. Cecil textbook of medicine. Philadelphia: WB Saunders Company, 1988: 410-19.
19. 19 Richardson SGN, Matthews KB, Cruickshank JK, Geddes AM, Stuart J. Coagulation activity and hyperviscosity in infection. Br J Haemat 1979; 42: 469-80.
20. 20 Mattila K, Rasi V, Nieminen M, et al. Von Willebrand factor antigen and dental infections. Thromb Res 1989; 56: 325-29.
21. 21 Sammalkorpi K. Glucose intolerance and acute infections. J Int Med 1989; 225: 15-19.
22. 22 Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E, Taskinen M-R. Changes in serum lipoprotein pattern induced by acute infection. Metabolism 1988; 37: 859-65.
23. 23 Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur Heart J 1993; 14 (suppl K): 2-6.
24. 24 Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary artery disease in men. N Engl J Med 1993; 328: 1450-56.
25. 25 Khaw K-T, Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. BMJ 1995; 310: 1559-63.
26. 26 Hubbard RC, Crystal RG. Vulnerability of lung to proteolytic injury. In: Crystal RG, West JB, Barnes PJ, Cherniack NS, Weibel ER. The lung scientific foundations. New York: Raven Press, 1991: 2059-71.
27. 27 Totani L, Piccoli A, Pellegrini G, di Santo A, Lorenzet R. Polymorphonuclear leucocytes enhance release of growth factors by cultured endothelial cells. Arterio Thrombosis 1994; 14: 125-32.
28. 28 Vartiainen e, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994; 309: 23-27.
29. 29 Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J. Twenty year trends in coronary risk factors in North Karelia and in other areas in Finland. Int J Epidemiol 1994; 23: 495-503.
30. 30 Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P. Effect of risk factors and changes in risk factors on coronary mortality in three cohorts of middle-aged people in eastern Finland. Am J Epidemiol 1995; 141: 50-60.